Ethambutol Hydrochloride

證據等級: L5

預測適應症: 0 個

---

目錄

1. Ethambutol Hydrochloride
2. Ethambutol Hydrochloride: Drug Repurposing Evaluation Report
   1. One-Sentence Summary
   2. Quick Overview
   3. Conclusion and Next Steps
   4. Disclaimer

---

## 藥師評估報告

Ethambutol Hydrochloride: Drug Repurposing Evaluation Report

One-Sentence Summary

Ethambutol Hydrochloride is a first-line antimycobacterial agent used in the treatment of active tuberculosis. The current Evidence Pack contains no TxGNN-predicted new indications for this drug — the model output is absent and essential data fields (DrugBank ID, MOA, safety warnings) have not been populated. This report reflects the current data state and recommends a Hold pending resolution of upstream data gaps.

---

Quick Overview

Item	Content
Original Indication	Not populated in Evidence Pack
Predicted New Indication	No predictions available
TxGNN Prediction Score	—
Evidence Level	Not determinable
Canada Market Status	Not marketed (per Evidence Pack)
Number of DINs	0
Recommended Decision	Hold

---

Conclusion and Next Steps

Decision: Hold

Rationale: The Evidence Pack for Ethambutol Hydrochloride is currently in an incomplete state — predicted_indications is empty and all drug-level data fields (DrugBank ID, MOA, original indications, safety warnings) are unpopulated. Without a TxGNN prediction output and baseline drug data, no repurposing evaluation can be conducted.

To proceed, the following is needed:

• Re-run TxGNN pipeline for Ethambutol Hydrochloride to generate predicted indication candidates with scores
• Resolve DrugBank mapping — the query log shows a successful DrugBank lookup (result_count: 1) but drugbank_id is null; investigate the mapping failure and re-populate original_moa, original_indications, and DrugBank categories
• Verify Canada market status — Health Canada DIN records should be re-queried; Ethambutol HCl is a well-established antimycobacterial agent and the “Not marketed” status warrants confirmation
• Obtain package insert safety data — retrieve Health Canada product monograph to populate key_warnings and contraindications (currently blocking the S1 safety screening step per DG001)
• Re-generate Evidence Pack after above gaps are resolved before proceeding to full repurposing evaluation

---

⚠️ Data Status Notice

This report could not be fully evaluated due to critical upstream data gaps (DG001: Safety warnings — Blocking; DG002: MOA — High severity). The DrugBank query on 2026-03-25 returned 1 result but was not integrated into the Evidence Pack. Remediation should be prioritised before this candidate re-enters the evaluation pipeline.

Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.

---